What should I Know Regarding Pregnancy, Nursing and Administering XYLOCAINE WITH EPINEPHRINE Vial to Children or the Elderly?

If you are PREGNANT

  • FDB Only When Necessary: INSUFFICIENT HUMAN DATA AVAILABLE.
  • FDB Only When Necessary: INSUFFICIENT HUMAN DATA AVAILABLE

If you are NURSING

  • No Known Risk: AMOUNT EXCRETED REPORTED TO BE LOW WITH LOW INFANT ORAL BIOAVAILABILITY
  • Precaution: POOR ORAL BIOAVAILABILITY AND SHORT HALF-LIFE; UNLIKELY TO AFFECT INFANT.

If you are an adult over 60

  • management or monitoring precaution: General-May be more sensitive to CNS and cardiac adverse reactions. Consider dose reduction due to reduced clearance in the elderly.
  • management or monitoring precaution: Cardiovascular-Increased risk of cardiovascular side effects: tachycardia, Neuro/Psych-Increased risk of neuropsychological adverse events.

Giving XYLOCAINE WITH EPINEPHRINE Vial to a child under 12

  • Severe Precaution: Rare risk of methemoglobinemia in infants age < 6 months. Risk of systemic toxicity. Monitor for CNS toxicity (e.g. restlessness, dizziness, drowsiness, blurred vision) with prolonged infusion, repeated injections or application. Limited safety data available.

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.